drugset
drugset / Trial / NCT02047201

Assessing Tumor Response and IMRT Treat Plan After IC Based on FDG-PET/CT for Locally Advanced HNSCC

NCT02047201 ↗

Phase 2 Completed 40 enrolled Lithuanian University of Health Sciences
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the safety and efficacy of cisplatin plus intensity-modulated radiotherapy (IMRT) based on FDG-PET/CT after induction chemotherapy (IC) for locally advanced head and neck squamous cell carcinoma.

Timeline

Start
2013-06
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified 75 mg/m2 Intravenous
Subject Docetaxel Small molecule 75 mg/m2 Intravenous
Subject fluorouracil Small molecule 750 mg/m2 Intravenous

Indications

head and neck squamous cell carcinoma